SMR – Modulating RNA with Oligonucleotides or Small Molecules

You are here:

Join us on Friday 21 June 2024 at the GSK Medicines Research Centre in Stevenage, UK for a one-day conference on RNA Modulating Therapies,  sponsored by Charnwood Discovery.  

About the SMR's Modulating RNA with Oligonucleotides or Small Molecules Event

This meeting will delve into the latest advancements in this rapidly evolving field as expert speakers cover successful approaches, future opportunities, and safety considerations. 

The morning session will explore oligonucleotide approaches, while the afternoon session will focus on small molecule strategies. It will be a great opportunity to learn from industry and academic leaders, network with peers, and stay ahead in the realm of therapeutic innovation.

Meet the Team

Come by or stand at the symposium to meet with Dr Francesca Sadler, CCO and Dr Alex Scollan, Senior Research Scientist. 

Alex is one of our oligonucleotides experts within the company, having spent time working on them during his PhD. He has since applied his synthetic chemistry knowledge on a vast range of projects at Charnwood Discovery. 

If you would like to arrange a meeting with the team please click the link below:

Register for the SMR Meeting

Learn more about the event, program and how you can attend the event here:

Innovation drives our small molecule drug discovery program. Our medicinal chemistry teams have access to cutting-edge tools allowing for creative design and synthesis of molecules.

By having all our specialist, expert teams under one roof it enables easy collaboration and idea generation. Consequently, client projects move forward swiftly whilst always having data to support any decisions being made.

Share this post: